glp-1 receptor agonist use and risk of suicide death Cardiovascular mortality outcomes with agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Benefit-Risk Assessment of GLP-1 Receptor
Description
The decision should be clinical, not based on convenience alone
Dehydration represents an important factor, as GLP-1 medications can cause nausea, vomiting, and diarrhea, particularly during dose escalation, leading to volume depletion
The Payment Model Hers does not require insurance
A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis
Mells JE, Anania FA
